198 related articles for article (PubMed ID: 18840485)
1. Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin.
Hong M; Zhu S; Jiang Y; Tang G; Pei Y
J Control Release; 2009 Jan; 133(2):96-102. PubMed ID: 18840485
[TBL] [Abstract][Full Text] [Related]
2. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
[TBL] [Abstract][Full Text] [Related]
3. Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo.
Hatakeyama H; Akita H; Maruyama K; Suhara T; Harashima H
Int J Pharm; 2004 Aug; 281(1-2):25-33. PubMed ID: 15288340
[TBL] [Abstract][Full Text] [Related]
4. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
[TBL] [Abstract][Full Text] [Related]
5. [Studies on the preparation of camptothecin niosomes].
Luan LB; Zhu JB; Yu WP; Wei KB
Yao Xue Xue Bao; 2002 Jan; 37(1):59-62. PubMed ID: 12579902
[TBL] [Abstract][Full Text] [Related]
6. Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system.
Kakudo T; Chaki S; Futaki S; Nakase I; Akaji K; Kawakami T; Maruyama K; Kamiya H; Harashima H
Biochemistry; 2004 May; 43(19):5618-28. PubMed ID: 15134436
[TBL] [Abstract][Full Text] [Related]
7. Targeting liposomes with protein drugs to the blood-brain barrier in vitro.
Visser CC; Stevanović S; Voorwinden LH; van Bloois L; Gaillard PJ; Danhof M; Crommelin DJ; de Boer AG
Eur J Pharm Sci; 2005 Jun; 25(2-3):299-305. PubMed ID: 15911226
[TBL] [Abstract][Full Text] [Related]
8. Transferrin-mediated targeting of hypericin embedded in sterically stabilized PEG-liposomes.
Derycke AS; De Witte PA
Int J Oncol; 2002 Jan; 20(1):181-7. PubMed ID: 11743662
[TBL] [Abstract][Full Text] [Related]
9. Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME).
Tanaka T; Shiramoto S; Miyashita M; Fujishima Y; Kaneo Y
Int J Pharm; 2004 Jun; 277(1-2):39-61. PubMed ID: 15158968
[TBL] [Abstract][Full Text] [Related]
10. Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting.
Brigger I; Morizet J; Aubert G; Chacun H; Terrier-Lacombe MJ; Couvreur P; Vassal G
J Pharmacol Exp Ther; 2002 Dec; 303(3):928-36. PubMed ID: 12438511
[TBL] [Abstract][Full Text] [Related]
11. [Transferrin conjugated PEG-liposomes as intracellular targeting carrier for tumor therapy].
Ishida O; Maruyama K
Nihon Rinsho; 1998 Mar; 56(3):657-62. PubMed ID: 9549352
[TBL] [Abstract][Full Text] [Related]
12. Camptothecin delivery systems: the utility of amino acid spacers for the conjugation of camptothecin with polyethylene glycol to create prodrugs.
Conover CD; Greenwald RB; Pendri A; Shum KL
Anticancer Drug Des; 1999 Dec; 14(6):499-506. PubMed ID: 10834271
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates.
Gabizon A; Shmeeda H; Horowitz AT; Zalipsky S
Adv Drug Deliv Rev; 2004 Apr; 56(8):1177-92. PubMed ID: 15094214
[TBL] [Abstract][Full Text] [Related]
14. Transferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cells.
Derycke AS; Kamuhabwa A; Gijsens A; Roskams T; De Vos D; Kasran A; Huwyler J; Missiaen L; de Witte PA
J Natl Cancer Inst; 2004 Nov; 96(21):1620-30. PubMed ID: 15523091
[TBL] [Abstract][Full Text] [Related]
15. Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo.
Ishida O; Maruyama K; Tanahashi H; Iwatsuru M; Sasaki K; Eriguchi M; Yanagie H
Pharm Res; 2001 Jul; 18(7):1042-8. PubMed ID: 11496943
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery.
Xu Z; Gu W; Huang J; Sui H; Zhou Z; Yang Y; Yan Z; Li Y
Int J Pharm; 2005 Jan; 288(2):361-8. PubMed ID: 15620876
[TBL] [Abstract][Full Text] [Related]
17. Pentapeptide YIGSR-mediated HT-1080 fibrosarcoma cells targeting of adriamycin encapsulated in sterically stabilized liposomes.
Lopez-Barcons LA; Polo D; Reig F; Fabra A
J Biomed Mater Res A; 2004 Apr; 69(1):155-63. PubMed ID: 14999763
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles bearing polyethyleneglycol-coupled transferrin as gene carriers: preparation and in vitro evaluation.
Li Y; Ogris M; Wagner E; Pelisek J; Rüffer M
Int J Pharm; 2003 Jun; 259(1-2):93-101. PubMed ID: 12787639
[TBL] [Abstract][Full Text] [Related]
19. PEGylated polycyanoacrylate nanoparticles as salvicine carriers: synthesis, preparation, and in vitro characterization.
Li YP; Zhou ZH; Pei YY; Zhang XY; Gu ZH; Yuan WF
Acta Pharmacol Sin; 2001 Jul; 22(7):645-50. PubMed ID: 11749831
[TBL] [Abstract][Full Text] [Related]
20. In vitro cytotoxicity and in vivo distribution after direct delivery of PEG-camptothecin conjugates to the rat brain.
Fleming AB; Haverstick K; Saltzman WM
Bioconjug Chem; 2004; 15(6):1364-75. PubMed ID: 15546204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
